Regencell Bioscience Holdings (RGC) Short-term Investments (2022 - 2025)

Regencell Bioscience Holdings has reported Short-term Investments for 4 years, with the latest figure at $2.5 million in Q2 2025.

• For the quarter ending Q2 2025, Short-term Investments fell 50.44% year-over-year to $2.5 million; the trailing twelve-month figure through Jun 2025 stood at $2.5 million (down 50.44% YoY), and the FY2025 full-year result was $2.5 million, down 50.44% from the prior year.
• Short-term Investments for Q2 2025 stood at $2.5 million, down from $5.0 million in the prior quarter.
• The five-year high for Short-term Investments was $10.0 million in Q2 2022, with the low at $2.5 million in Q2 2025.
• Historically, Short-term Investments has averaged $6.9 million across 4 years, with a median of $7.5 million in 2022.
• Annual changes were most pronounced in 2023 — Short-term Investments changed 0.0% — and 2025, when it plunged 50.44%.
• Regencell Bioscience Holdings' Short-term Investments stood at $10.0 million in 2022, then changed by 0.0% to $10.0 million in 2023, then slumped by 50.0% to $5.0 million in 2024, then sank by 50.44% to $2.5 million in 2025.
• The last three Short-term Investments figures came in at $2.5 million (Q2 2025), $5.0 million (Q2 2024), and $10.0 million (Q2 2023), per Business Quant data.